IDSA leads the way in detecting, preventing, treating and curing infectious diseases worldwide. We are updating this resource center daily with must-have information for clinicians and decision-makers.
COVID-19 Featured Resources
Dr. Fauci’s Message to IDSA Members
Dr. Fauci, NIAID Director, recognizes ID specialists and other front-line health care workers.
COVID-19: Clinical Trials & Registries
We discuss clinical trials and registries as they relate to the COVID-19 pandemic and their importance in combating the virus.
IDSA's Response to COVID-19
H.R.6800, the Health Heroes Act, includes policies and investments that would bolster the federal response to COVID-19, increase testing capacity and availability of medical supplies and address the disparate impact of COVID-19 on vulnerable populations.
The U.S. Department of Health and Human Services decision allowing state health departments to distribute limited supplies of remdesivir to treat COVID-19 where they are needed will support fair and equitable access to the drug.
Strong and specific federal guidance is critical to protecting our country, our communities, our health and our lives in the face of the still escalating impacts of COVID-19 across the United States.
With FDA emergency authorization of remdesivir to treat COVID-19, the Infectious Diseases Society of America and its HIV Medicine Association are calling on Vice President Mike Pence and other administration officials to provide public transparency in the process for determining how and where the medication is distributed